SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gland Pharma informs about outcome of board meeting

03 Nov 2025 Evaluate

In continuation to intimation dated October 17, 2025, regarding the Board Meeting Notice, Gland Pharma has informed that the Board of Directors of the Company at its Meeting held today, Monday, November 03, 2025, has considered and approved the Unaudited Financial Results (standalone and consolidated) along with the Limited Review Report(s) for the quarter and half year ended September 30, 2025, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations’) which has been duly reviewed and recommended by the Audit Committee. In this regard, the company has enclosed copies of the: 1. Unaudited Financial Results (standalone and consolidated) along with Limited Review Report(s) of the Company for the quarter and half year ended September 30, 2025, prepared in compliance with Indian Accounting Standards (Ind AS). 2. Press Release and Investor Presentation on the financial results of the Company for the above period. The Board Meeting commenced at 15.00 Hrs. IST and ended at 16.10 Hrs. IST.

The above information is a part of company’s filings submitted to BSE.  

Gland Pharma Share Price

1795.80 59.80 (3.44%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×